Last updated: Nov 20, 2026, 12:00 AM

MoonLake Immunotherapeutics Exchange (NASDAQ, USD)

MLTX

10.79
-0.46 (-4.09%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-16.94%
3 year return (CAGR)
-33.49%
5 year return (CAGR)
1.68%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
918.30M
Price/Sales
-
Ent value
697.68M
Price/Book
2.41
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open11.18
Daily high11.29
Daily low10.78
Daily Volume1.32M
All-time high63.86
1y analyst estimate28.54
Beta1.13
EPS (TTM)-3.20
Dividend per share0.00
Ex-div date-
Next earnings date26 Feb 2026

Ready to capitalize on MoonLake Immunotherapeutics's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
MLTXS&P500
Current price drop from All-time high-83.10%-6.28%
Highest price drop-90.22%-56.47%
Date of highest drop29 Sep 20259 Mar 2009
Avg drop from high-32.90%-10.64%
Avg time to new high28 days12 days
Max time to new high696 days1805 days